TIRmed Pharma
PrivateLast Round
Series A
Apr 9, 2025
Total Funding Raised
$5.41M
Company Overview
TIRmed Pharma is a biotechnology company developing a next-generation, topical oligonucleotide-based treatment for autoimmune skin diseases, with an initial focus on atopic dermatitis (eczema).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TIRmed Pharma Comps
Public and private peers based on sector, stage, and business model.
TIRmed Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Early Funding | Nov 20, 2020 |
Key People
Founding team and executive leadership
TIRmed Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vinnova | Grant |
| Sciety | Series A |
| Swelife | Grant |
| Almi Invest | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Partnered with Bachem Americas, Inc. for atopic dermatitis therapy.
- Nov 6, 2025
Strengthening collaboration with Zelmic AB.
TIRmed Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TIRmed Pharma's valuation, stock price, and market status.
